---
$id: https://graph.org.ai/products/commodity/51361904
$type: Product
source: UNSPSC
code: "51361904"
title: "Aprobarbital"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Aprobarbital

**UNSPSC Code**: 51361904
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C10H14N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q0YKG9L6RF, chemically known as 2,4,6 (1h,3h,5h)-pyrimidinetrione, 5-(1-methylethyl)-5-(2-propenyl)-, monosodium salt but generally known as aprobarbital, which bears US NIH Compound Identifier 6464. Aprobarbital most often comes in base, o,o-dimethyl-epoxide, natrium, and sodium forms. European Medicines Agency schedules Aprobarbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05543MIG. The term APROBARBITAL is an International Non-Proprietary Name. World Health Organization schedules aprobarbital in its Anatomical Therapeutic Chemical (ATC) Classification. APROBARBITAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aprobarbital under HS 29335400 and SITC kg. As of Q4 2014, APROBARBITAL remains the US FDA Preferred Term for this commodity. Aprobarbital bears US NLM identifiers UMLS ID C0051241 and NCI Concept Code C76525. SMILES: CC(C)C1(C(=O)NC(=O)NC1=O)CC=C.

